Related Articles
Trabectedin in combination with pegylated liposomal doxorubicin in patients with ovarian tumors
Disease-adapted relapse therapy for ovarian cancer: results of a prospective study.
Redistribution of resistance and sensitivity to platinum during the observation period following treatment of epithelial ovarian cancer
Combination of irinotecan and platinum for platinum-resistant or refractory recurrent ovarian cancers: A preliminary case series
Efficacy and safety of antiangiogenic therapy (bevacizumab or apatinib) plus chemotherapy in patients with platinum‑resistant recurrent ovarian cancer: A retrospective study